אקוואפאס בע"מ

AquaPass is a breakthrough, first-of-its-kind, non-invasive treatment system for removing fluid overload in Chronic Heart Failure and End-Stage Renal Disease patients that bypasses the renal system and extracts fluid through the eccrine glands.

A novel treatment and technology that will change and disrupt the way physicians and patients are treating Edema caused by congestive heart, kidney failure or other diseases.

Physicians, Patients, suffering from interstitial Edema.

Noam Josephy - CEO

Yaacov Nitzan - CTO & Co-Founder